| |
Interventional Pharmacology and Cardiovascular Prevention - Part 1 |
| |
|
| |
8:30 AM-12:30 PM, March 22, 2008, Hall #305 |
| |
|
| |
Section 1: Fundamental Knowledge and Clinical Relatives |
| |
|
|
| |
Moderator |
Dingyin Zeng
Jianjun Li
Xuesi Wu |
| |
|
|
| |
8:30 AM |
Arteriosclerosis and Restenosis: Strategies of Drug Prevention and Therapy
Ping Ye |
| |
|
|
| |
8:50 AM |
Vascular Biology Following PCI: Pathophysiology and Drug Intervention
Jun Tao  |
| |
|
|
| |
9:10 AM |
Unstable Plaque and Plaque Stabilization: Role of Drug Therapy
Jianjun Li |
| |
|
|
| |
9:30 AM |
Application of Antithrombin Agents Following PCI
Jinqing Yuan |
| |
|
|
| |
9:50 AM |
Application of Antiplatelet Agents Following PCI
Guangping Li |
| |
|
|
| |
10:10 AM |
Application of Statins Following PCI
Hong Chen |
| |
|
|
| |
Section 2: Cardiovascular Comprehensive Risk Factor Interventions |
| |
|
|
| |
Moderator |
Weifeng Shen
Ping Ye
Meilin Liu |
| |
|
|
| |
10:30 AM |
Bridging the Gap on CHD Secondary Prevention: The Latest Results of BRIG Research
Dong Zhao |
| |
|
|
| |
11:00 AM |
BP Lowering Strategy for CHD Patient: 2007 ACC/AHA Statement for the Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease
Jiguang Wang |
| |
|
|
| |
11:30 AM |
Lipid-Lowering Strategies in High Risk Patients: What Was Known, What Is New and What Is Next?
Weifeng Shen |
| |
|
|
| |
12:00 PM |
The Crucial Role of Evidence-Based Studies in the Prevention and Treatment of Cardiovascular diseases
Dejia Huang |
| |
|
|
| |
12:30 PM |
Adjourn |
| |
|
|
| |
|
|
| |
Interventional Pharmacology and Cardiovascular Prevention - Hot Lunch, Hot Debate |
| |
|
|
| |
12:45 PM-1:45 PM, March 22, 2008, Hall #305 |
| |
|
|
| |
Moderator |
Jianjun Li |
| |
|
|
| |
Discussant |
Junzhu Chen
Hong Ma |
| |
|
|
| |
12:45 PM |
Introduction and Objective |
| |
|
|
| |
Topic: Revascularization or Medication, Which One We Should Choose for CHD Therapy? |
| |
|
|
| |
12:48 PM |
Revascularization (PCI or CABG)
Shuzheng Lu |
| |
|
|
| |
1:08 PM |
Medication
Shuiping Zhao |
| |
|
|
| |
1:28 PM |
Panel Discussion |
| |
|
|
| |
1:42 PM |
Conclusion |
| |
|
|
| |
1:45 PM |
Adjourn |
| |
|
|
| |
|
|
| |
Interventional Pharmacology and Cardiovascular Prevention - Part 2 |
| |
|
|
| |
2:00 PM-6:00 PM, March 22, 2008, Hall #305 |
| |
|
|
| |
Moderator |
Yuejin Yang
Yan Li |
| |
|
|
| |
2:00 PM |
Opening Speech
Yuejin Yang |
| |
|
|
| |
2:05 PM |
From Intervention to Prevention
Xiaoying Li |
| |
|
|
| |
2:35 PM |
Antithrombotic Therapy in CVD Patients
Xiaowei Yan |
| |
|
|
| |
3:05 PM |
PCI and Drug Therapy Strategy in Diabetic Patients
Yongjian Wu |
| |
|
|
| |
3:35 PM |
Blood Glucose Management in PCI Patients
Farong Shen |
| |
|
|
| |
4:05 PM |
Tea Break |
| |
|
|
| |
4:20 PM |
Antiplatelet Drug Resistance
Zhongwei Shi |
| |
|
|
| |
4:50 PM |
How to Balance the Benefit and Risk of Antiplatelet Therapy: Case-Based Discussion
Ben He |
| |
|
|
| |
5:15 PM |
Complex PCI of Diabetic Patient: Case-Based Discussion
Yundai Chen |
| |
|
|
| |
5:40 PM |
Panel Discussion and Q&A |
| |
|
|
| |
5:55 PM |
Conclusion |
| |
|
|
| |
6:00 PM |
Adjourn |
| |
|
|
